AI Technology Group Inc. amended its merger agreement with Biomed 360 Solutions and AVM Biotechnology, extending the closing date and revising investment obligations totaling up to $50M. The deal now targets an OTCQB listing with potential senior exchange uplift pending broker-dealer engagement.